Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

402

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 8 drugs with upcoming expirations

Activity

Key Events

Jul 13, 2026FDAZithromax — ZITHROMAX

Dec 22, 2025FDAUltiva — ULTIVA

Jun 16, 2025FDAInspra — INSPRA

May 28, 2025FDACortef — KHINDIVI

4 more events

Jan 30, 2021TrialA Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form

Dec 17, 2019TrialAn Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants

Dec 21, 2018TrialExtension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder

Nov 6, 2018TrialRelative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

18 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Lyrica3 patentsNov 2, 2026 Lyrica3 patentsMay 2, 2027 VibramycinDec 19, 2027 DoryxFeb 3, 2028 DeltasoneOct 11, 2028 XalatanOct 15, 2028 YupelriOct 31, 2028 XalatanSep 12, 2029

10 more

Yupelri5 patentsJul 14, 2030 XalatanJul 8, 2031 YupelriAug 25, 2031 CortefNov 19, 2032 CortefJan 10, 2033 CortefMay 12, 2034 Doryx3 patentsOct 23, 2034 Lipitor6 patentsJun 7, 2037 Yupelri3 patentsAug 29, 2039 Cortef2 patentsFeb 23, 2043

Regulatory

Regulatory Timeline

20231 event

FDADec 20

Cortef — SOLU-CORTEF

Application NDA009866

20246 events

FDANov 21

Celebrex — CELEBREX

Application NDA020998

FDAJul 15

Doryx — DORYX MPC, DORYX

Application NDA050795

FDAJul 10

Cortef — SOLU-CORTEF

Application NDA009866

FDAJun 5

Cortef — SOLU-CORTEF

Application NDA009866

FDAJun 5

Cortef — CORTEF

Application NDA008697

FDAApr 2

Lipitor — LIPITOR

Application NDA020702

20259 events

FDADec 22

Ultiva — ULTIVA

Application NDA020630

FDADec 22

Ultiva — ULTIVA

Application NDA020630

FDAJun 16

Inspra — INSPRA

Application NDA021437

FDAMay 28

Cortef — KHINDIVI

Application NDA218980 (NDA)

FDAMay 28

Cortifoam — KHINDIVI

Application NDA218980 (NDA)

FDAApr 25

Lyrica — LYRICA

Application NDA021446

FDAApr 25

Lyrica — LYRICA

Application NDA022488

FDAApr 25

Lyrica — LYRICA CR

Application NDA209501

FDAMar 31

Doryx — DORYX MPC, DORYX

Application NDA050795

20264 events

FDAJul 13

Zithromax — ZITHROMAX

Application NDA050711

FDAJul 13

Zithromax — ZITHROMAX

Application NDA050784

FDAJul 13

Zithromax — ZITHROMAX

Application NDA050733

FDAJul 13

Zithromax — ZITHROMAX

Application NDA050710

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)